Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw Open. 2020;3(9):e2023121.

Deva AK, Turner SD, Kadin ME, Magnusson MR, H Prince M, Miranda RN, et al. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers (Basel). 2020;12(12).

Casiraghi N, Orlando F, Ciani Y, Xiang J, Sboner A, Elemento O, et al. ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA. Bioinformatics. 2020;36(9):2665-2674.

Goyal A, Patel AP, Dilcher TL, Alperstein SA. Effects of Implementing the Dual Papanicolaou Test Interpretation of ASC-H and LSIL Following Bethesda 2014. Am J Clin Pathol. 2020;154(4):553-558.

Chung HH, Morjaria S, Frame J, Riley M, Zhang AW, Martin SC, et al. Rethinking the need for a platelet transfusion threshold of 50 × 10 /L for lumbar puncture in cancer patients. Transfusion. 2020;60(10):2243-2249.

Prutsch N, Gurnhofer E, Suske T, Liang HC, Schlederer M, Roos S, et al. Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2020;34(11):3105.

Cheleuitte-Nieves C, Heselpoth RD, Westblade LF, Lipman NS, Fischetti VA. Searching for a Bacteriophage Lysin to Treat in Immunocompromised Mice. Comp Med. 2020;70(4):328-335.

Wang Q, Jia S, Wang D, Chen X, Kalvakolanu DV, Zheng H, et al. A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis. Mol Cancer Ther. 2020;19(12):2542-2553.

Fischer K, Fenzl A, Liu D, Dyar KA, Kleinert M, Brielmeier M, et al. The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation. Nat Commun. 2020;11(1):2306.

Schatz-Siemers N, Chen Y-, Chen Z, Wang D, Ellenson LH, Du Y-. Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression. Appl Immunohistochem Mol Morphol. 2020;28(6):453-459.